Trials / Completed
CompletedNCT05977465
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
Clinical Study to Investigate the Possible Effect of Empagliflozin in Treatment of Peripheral Diabetic Neuropathy in Patients With Diabetes Mellitus Type 2
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to investigate the possible protective effect of empagliflozin in patients with type 2 diabetes mellitus with diabetic peripheral neuropathy and not on SGLT2 inhibitors treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Empagliflozin 25 MG | treatment |
Timeline
- Start date
- 2022-01-20
- Primary completion
- 2023-08-01
- Completion
- 2023-08-03
- First posted
- 2023-08-04
- Last updated
- 2023-11-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05977465. Inclusion in this directory is not an endorsement.